Trupanion, Inc. (NASDAQ:TRUP) Receives Average Rating of “Moderate Buy” from Analysts

Trupanion, Inc. (NASDAQ:TRUP) has earned a consensus recommendation of “Moderate Buy” from the six research firms that are presently covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, two have given a hold recommendation, two have given a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year target price among analysts that have issued a report on the stock in the last year is $51.00.

Several brokerages have weighed in on TRUP. Zacks Research raised Trupanion from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, January 6th. Cantor Fitzgerald dropped their price objective on Trupanion from $50.00 to $42.00 and set a “neutral” rating on the stock in a report on Wednesday, January 14th. Stifel Nicolaus reduced their target price on shares of Trupanion from $45.00 to $42.00 and set a “hold” rating for the company in a research note on Tuesday, November 18th. Piper Sandler dropped their price target on shares of Trupanion from $67.00 to $60.00 and set an “overweight” rating on the stock in a research note on Friday, December 19th. Finally, Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Trupanion in a research note on Monday, December 29th.

Trupanion Stock Up 1.7%

Trupanion stock opened at $31.75 on Thursday. Trupanion has a twelve month low of $30.85 and a twelve month high of $57.88. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.71 and a current ratio of 1.71. The firm has a market cap of $1.37 billion, a PE ratio of 88.20 and a beta of 1.58. The firm’s 50 day moving average price is $36.21 and its two-hundred day moving average price is $42.22.

Trupanion (NASDAQ:TRUP) last posted its quarterly earnings results on Thursday, November 6th. The financial services provider reported $0.13 EPS for the quarter, missing the consensus estimate of $0.89 by ($0.76). Trupanion had a net margin of 1.10% and a return on equity of 4.48%. The company had revenue of $366.92 million for the quarter, compared to analysts’ expectations of $361.58 million. During the same quarter in the prior year, the firm earned $0.03 earnings per share. The company’s revenue was up 12.0% on a year-over-year basis. On average, research analysts predict that Trupanion will post 0.13 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, CEO Margaret Tooth sold 9,605 shares of the company’s stock in a transaction dated Friday, December 19th. The stock was sold at an average price of $37.88, for a total transaction of $363,837.40. Following the completion of the sale, the chief executive officer owned 150,294 shares in the company, valued at approximately $5,693,136.72. This represents a 6.01% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CFO Fawwad Qureshi sold 6,202 shares of the firm’s stock in a transaction that occurred on Wednesday, November 26th. The shares were sold at an average price of $35.45, for a total value of $219,860.90. The SEC filing for this sale provides additional information. Insiders sold 41,307 shares of company stock valued at $1,556,742 over the last quarter. Insiders own 5.42% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in TRUP. Millennium Management LLC lifted its stake in shares of Trupanion by 185.8% in the third quarter. Millennium Management LLC now owns 619,003 shares of the financial services provider’s stock valued at $26,790,000 after buying an additional 402,421 shares during the period. Two Sigma Investments LP increased its stake in Trupanion by 3,201.0% during the third quarter. Two Sigma Investments LP now owns 224,433 shares of the financial services provider’s stock valued at $9,713,000 after acquiring an additional 217,634 shares during the period. Marshall Wace LLP raised its holdings in Trupanion by 15.5% in the 3rd quarter. Marshall Wace LLP now owns 1,212,151 shares of the financial services provider’s stock valued at $52,462,000 after acquiring an additional 163,101 shares in the last quarter. Tudor Investment Corp ET AL lifted its position in shares of Trupanion by 183.7% in the 3rd quarter. Tudor Investment Corp ET AL now owns 237,125 shares of the financial services provider’s stock worth $10,263,000 after acquiring an additional 153,530 shares during the period. Finally, UBS Group AG lifted its position in shares of Trupanion by 183.1% in the 3rd quarter. UBS Group AG now owns 176,289 shares of the financial services provider’s stock worth $7,630,000 after acquiring an additional 114,021 shares during the period.

Trupanion Company Profile

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.